Breakthrough in Selective Remote Dihalogenation Unveiled by CAS Dalian Institute

On March 5, 2026, the Dalian Institute of Chemical Physics (DICP) under the Chinese Academy of Sciences (CAS) announced a groundbreaking advancement in organic synthesis. Researchers led by Prof. Qing-An Chen have developed a phosphordiamidate-catalyzed strategy for the remote dihalogenation of alkenes, enabling highly selective production of 1,3-, 1,4-, and 2,3-dihalogenation products without the need for directing groups. This innovation, detailed in a recent Journal of the American Chemical Society (JACS) publication, promises to transform how chemists construct complex organic halides essential for pharmaceuticals and advanced materials.

The method addresses longstanding limitations in alkene halogenation, where traditional approaches predominantly yield vicinal (1,2-) dihalides. By harnessing ester transposition, the DICP team achieves precise control over remote halogen placement, opening new pathways for molecular design in drug discovery and beyond.

The Critical Role of Organic Halides in Modern Chemistry

Organic halides serve as foundational building blocks in synthetic chemistry due to their unique reactivity and prevalence in bioactive molecules. Approximately 25% of all pharmaceuticals contain halogen atoms, which enhance metabolic stability, binding affinity, and lipophilicity. Halogenated compounds are also pivotal in agrochemicals, liquid crystals, and energy storage materials.

Alkenes, abundant and versatile feedstocks from petrochemicals or renewables, are ideal precursors for halides via halogenation. However, classical electrophilic addition yields only 1,2-dihalides, restricting access to 1,3-, 1,4-, or 2,3-isomers crucial for complex scaffolds. Prior strategies often required directing groups, harsh conditions, or metal catalysts with narrow scopes, limiting scalability and generality.

This DICP breakthrough circumvents these hurdles, providing a directing-group-free protocol under mild conditions, broadening the synthetic toolbox for Chinese and global chemists alike.

Unpacking the Phosphordiamidate-Catalyzed Mechanism

The core innovation lies in a phosphordiamidate catalyst that orchestrates ester transposition to direct halogen delivery remotely. Starting with allylic or homoallylic esters (terminal, internal, cis, or trans), the reaction employs N-bromosuccinimide (NBS) and thionyl chloride (SOCl₂) under mild temperatures.

Step-by-step: (1) The catalyst activates NBS/SOCl₂ to form a reactive halogenating intermediate. (2) Ester transposition migrates the carbonyl group, positioning the alkene for remote attack. (3) Selective radical or ionic halogen transfer installs dihalogens at desired sites, yielding products in high yields (up to 95%) and regioselectivities.

Preliminary mechanistic studies confirm catalyst cooperation with reagents, enabling transposition without pre-functionalization. This elegance stems from phosphordiamidate's dual role in activation and directing via hydrogen bonding or coordination.

Substrate Scope and Functional Group Tolerance

The protocol excels in versatility, accommodating unactivated alkenes with aryl, alkyl, or heteroatom substituents. Allylic esters yield 1,3-dihalides; homoallylic ones favor 1,4- or 2,3-regioisomers based on geometry.

• High yields (70-95%) across 50+ examples.
• Tolerates cyano, hydroxyl, ester, and amide groups.
• Gram-scale synthesis: 5g scale with 85% yield for key products.
• Stereoretention in cis/trans alkenes preserved in products.

Such robustness positions it for late-stage functionalization in natural product synthesis.Full scope in JACS paper

Photo by Markus Winkler on Unsplash

Derivatizations and Real-World Applications

Products undergo seamless transformations: Suzuki-Miyaura cross-couplings install aryl groups; nucleophilic substitutions yield ethers/amines; cyclizations form heterocycles. These enable rapid assembly of pharmaceutical motifs like fluorinated analogs or halogenated amino acids.

In China, where fine chemical production surges (over 40% global share), this method supports domestic API synthesis. For instance, remote iodination products could streamline thyroid hormone analogs production.

Explore research positions advancing such catalysis at higher-ed research jobs across China.

Prof. Qing-An Chen and the DICP Legacy

Prof. Chen, a DICP Professor since 2009, earned his PhD there in 2012 under Yong-Gui Zhou. A Humboldt Fellow (2015-2017, TU Berlin), his lab focuses on asymmetric catalysis and biomimetic synthesis. Team members include PhD students Chang-Hui Liu, Yilitabaier Julaiti, Zhi-Yuan Ding, Yong-Zhu Hu, and Hao Zheng, many UCAS affiliates.

DICP, CAS's catalysis powerhouse, hosts 2000+ researchers, training PhD/MS students. This work exemplifies China's ascent in JACS publications (top 3 globally 2025).

Aspiring chemists: check China academic opportunities or professor jobs.

Implications for Pharmaceutical and Materials Innovation

Selective remote dihalogenation unlocks polyhalogenated scaffolds for PROTACs, kinase inhibitors. In materials, gem-dihalides aid polymer monomers; vinylic halides enable OLEDs.

China's pharma market ($200B+ 2026 proj.) benefits, reducing import reliance. Environmentally, mild conditions minimize waste vs. multi-step alternatives.

Comparative Advantages Over Existing Methods

This table highlights superiority in selectivity and practicality.

Photo by Artyom Korshunov on Unsplash

Future Directions and Broader Impacts

Prof. Chen envisions asymmetric variants for chiral halides and extension to trifluoromethylation. DICP's biomimetic focus may integrate enzymatic transposition.

In higher education, UCAS/DICP trains next-gen chemists; this inspires curricula in green synthesis. For career advice, visit higher ed career advice.

Conclusion: A Milestone for Chinese Catalysis Research

This phosphordiamidate breakthrough cements DICP's leadership, fostering innovation in China. Researchers eyeing catalysis roles should explore higher-ed jobs, university jobs, rate my professor, and career advice. Stay tuned for applications.